Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Quest Diagnostics Inc    DGX   US74834L1008

Delayed Quote. Delayed Nyse - 08/21 04:00:42 pm
62.77 USD   +0.37%
17h ago QUEST DIAGNOSTICS : Vermillion Reports 2Q 2014 Results
1d ago QUEST DIAGNOSTICS : Declares Quarterly Cash Dividend
1d ago QUEST DIAGNOSTICS : Declares Dividend
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Quest Diagnostics Inc
Provides diagnostic testing and information services

Quest Diagnostics, Inc. is engaged in providing diagnostic testing, information and services that help patients, physicians and others to make better healthcare decisions.

It offers patients and physicians the broadest access to diagnostic laboratory services through the company's nationwide network of laboratories and patient service centers.

The company's services range from routine blood tests such as cholesterol, Pap testing and white blood cell counts to cancer testing as well as gene-based and molecular testing.

It also offers clinical testing, which include gene-based and esoteric testing, anatomic pathology services and testing for drugs-of-abuse in the United States, and risk assessment services for the life insurance industry in North America and also manufactures and markets diagnostics products like diagnostic test kits and specialized point-of-care testing equipment.

The company empowers healthcare organizations and clinicians with information technology solutions that can improve patient care and medical practice.

Its non-clinical testing businesses consist of its risk assessment services, clinical trials testing, healthcare information technology, and diagnostics products businesses.

The company's risk assessment services business provides underwriting support services to the life insurance industry, which include specimen collection and paramedical examinations, laboratory testing, medical record retrieval, case management, motor vehicle reports, telephone inspections, prescription histories and credit checks.

Its clinical trials testing business provides clinical testing performed in connection with clinical research trials on new drugs, vaccines and certain medical devices.

The company's healthcare information technology business is a developer and integrator of clinical connectivity and data management solutions for healthcare organizations, physicians and clinicians that can help improve patient care and medical practice.

Its diagnostics products business manufactures and markets products that enable healthcare professionals to make healthcare diagnoses, including products for point-of-care testing for the professional market.

The company's Life Insurer services business provides risk assessment services to the life insurance industry in North America.

Quest Diagnostics was spun off from the Corning, Inc. as an independent company on December 31, 1996.

Quest Diagnostics was founded by Paul A. Brown in 1967 and is headquartered in Madison, NJ.

Number of employees : 41 000 persons.
Sales per Businesses
20122013Delta
USD (in Million)%USD (in Million)%
Diagnostics Information Services Business6,82092.4%6,58792.2% -3.54%
All Other Operating Segments562.657.6%559.007.8% -0.65%
Sales per Regions
20122013Delta
USD (in Million)%USD (in Million)%
United States7,23598%7,00398% -3.31%
International147.652%142.922% -3.31%
Managers
NameAgeSinceTitle
Stephen H. Rusckowski562012President, Chief Executive Officer & Director
Dan C. Stanzione, PhD681997Non-Executive Chairman
James E. Davis512013Senior Vice President-Operations
Mark J. Guinan, MBA522013Chief Financial Officer & Senior Vice President
Jon Roger Cohen, MD592009Chief Medical Officer & Senior Vice President
Lidia L. Fonseca, MBA452014Chief Information Officer & Senior Vice President
David Evans-2001Vice President-Information Technology
John C. Baldwin, MD652004Independent Director
Gail R. Wilensky, PhD701997Independent Director
Gary M. Pfeiffer, MBA642004Independent Director
Shareholders
NameShares%
The Vanguard Group, Inc. 10,390,2867.19%
Delaware Management Business Trust 7,529,2205.21%
T. Rowe Price Associates, Inc. 7,022,3594.86%
BlackRock Fund Advisors 6,720,9874.65%
SSgA Funds Management, Inc. 6,374,8474.41%
Merrill Lynch, Pierce, Fenner & Smith, Inc. 5,681,5463.93%
American Century Investment Management, Inc. 5,385,2493.73%
Capital Research & Management Co. (International Investors) 4,848,2003.36%
Davis Selected Advisers LP 4,672,6813.23%
BlackRock Advisors LLC 4,657,4853.22%
Holdings
NameShares%Valuation
GENOMIC VISION (GV) 616,15713.8%11,475,899 USD
Sector
Healthcare
Healthcare Services
 Healthcare Providers & Services
  Healthcare Facilities & Services
   Healthcare Facilities & Services - NEC
Advertisement
Surperformance© rating
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
PER
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector Healthcare Facilities & Services
Growth (Revenue) Profitability
HCA HOLDINGS INC
FRESENIUS MEDICAL..
DAVITA HEALTHCARE..
UNIVERSAL HEALTH ..
QUEST DIAGNOSTICS..
LABORATORY CORP. ..
COMMUNITY HEALTH ..
TENET HEALTHCARE ..
MEDNAX INC
NETCARE LIMITED
RHOEN-KLINIKUM AG
LIFE HEALTHCARE G..
TEAM HEALTH HOLDI..
HEALTHSOUTH CORP
LIFEPOINT HOSPITA..
RYMAN HEALTHCARE ..
BUMRUNGRAD HOSPIT..
ACADIA HEALTHCARE..
KORIAN-MEDICA
AIR METHODS CORP
Sector Healthcare Facilities & Services
Company contact information
Quest Diagnostics, Inc.
3 Giralda Farms
Madison, NJ 07940

Phone : +1.973.520.2700
Web : www.questdiagnostics.com
© 2014 Factset   
Dynamic quotes  
ON
| OFF